Further, NKX2-1 as a lineage-survival oncogene was reported in T cell acute lymphoblastic leukemia [3] and oncogenic ROR1 and LMO3 directly targeted by NKX2-1 promote lung adenocarcinoma progression [4, 5]. The gene discussed is NKX2-1; the disease is lung adenocarcinoma.